Compare VICR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VICR | SNN |
|---|---|---|
| Founded | 1981 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 12.3B |
| IPO Year | 1995 | 2002 |
| Metric | VICR | SNN |
|---|---|---|
| Price | $192.16 | $29.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $393.75 | $32.32 |
| AVG Volume (30 Days) | 954.5K | ★ 1.1M |
| Earning Date | 10-20-2026 | 08-04-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | ★ 1764.29 | N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $452,701,000.00 | N/A |
| Revenue This Year | $57.77 | $4.89 |
| Revenue Next Year | $52.22 | $5.25 |
| P/E Ratio | $499.61 | ★ $64.97 |
| Revenue Growth | ★ 26.08 | N/A |
| 52 Week Low | $57.55 | $26.30 |
| 52 Week High | $382.65 | $37.51 |
| Indicator | VICR | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 32.94 | 66.47 |
| Support Level | $169.82 | $28.87 |
| Resistance Level | $205.69 | $29.69 |
| Average True Range (ATR) | 18.57 | 0.41 |
| MACD | -11.45 | 0.33 |
| Stochastic Oscillator | 2.37 | 87.68 |
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. The principal markets for the Company's power converters and systems are large original equipment manufacturers (OEMs), original design manufacturers (ODMs) and their contract manufacturers, and smaller, lower volume users, which are broadly distributed across several market areas.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.